Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001104659-23-021541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-14 | 2023-02-10 | FBIO | Jin David | CFO | P - Purchase | $0.84 | +35.9K | 1.44M | +3% | +$30.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2023-02-10 | P | A | 35,928 | $0.84 | 1,438,757 | D | — | — | (F1) The total holdings include 1,350,000 shares underlying deferred restricted stock units. |